Login / Signup

The Chimera That Curbs Appetite.

Leonard G Luyt
Published in: Journal of medicinal chemistry (2018)
A chimeric drug design approach, merging the structure of an antagonist and an inverse agonist, results in a new molecular scaffold for targeting the ghrelin receptor (GHSR).
Keyphrases
  • cell therapy
  • weight loss
  • cancer therapy
  • tissue engineering
  • body weight
  • single molecule
  • stem cells
  • drug induced
  • binding protein
  • mesenchymal stem cells
  • growth hormone
  • electronic health record